Former Hims and Hers exec launches pediatric telehealth startup backed by Sequoia, Lux

Former Hims and Hers exec launches pediatric telehealth startup backed by Sequoia, Lux

As a mother of two young boys, Ellen DaSilva said she and other parents in the US feel “generally feel pretty underserved by the existing pediatric care infrastructure.” She and her husband have waited hours in the emergency room to obtain answers to simple questions about their children’s health, and they sometimes wait days for … Read more

Clinical trial sponsors need to take into consideration pandemic burnout

Clinical trial sponsors need to take into consideration pandemic burnout

Never before have clinical researchers had more options at their fingertips when designing a study. As technology leaps ahead, companies are sending more notifications, collecting larger amounts of data, and adding more apps, wearables, and ePROs to studies. But researchers need to be considerate about the fact that many potential participants are dealing with burnout, … Read more

Aiming to bring drug combos into earlier lines of cancer therapy, IDRx lands $122M

Aiming to bring drug combos into earlier lines of cancer therapy, IDRx lands 2M

A precision medicine is only as good as its target. While targeted therapies now address many types of cancer, tumors still frequently develop mutations that help them escape a drug. One strategy to address tumor escape is combining different cancer drugs. Biotech startup IDRx aims to use scientific knowledge of tumor biology to develop new … Read more

Lessons learned from prison and dialysis while trying to prevent the pain, loss and cost of kidney diseases

Lessons learned from prison and dialysis while trying to prevent the pain, loss and cost of kidney diseases

Cardiology has the heart attack, oncology has the fateful diagnosis date, but there is no “kidney attack” to serve as a traumatic wake-up call for those at risk of kidney diseases. There is no event to urgently change someone’s point of view; “From this moment forward, you will pay attention to your kidneys and do … Read more

Digital transformation: Reimagining clinical trial management

Digital transformation: Reimagining clinical trial management

Even before Covid-19 disrupted the traditional model for clinical trials, researchers were harnessing the power of technology to make trials more accessible and improve data collection. The movement had coalesced under the banner of decentralized clinical trials, or DCTs, which leverage technology and other non-traditional approaches to monitor patients and gather data without limits on … Read more

With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis

With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis

FDA approval of a new Arcutis Biotherapeutics drug for plaque psoriasis enables the company to roll out a strategy it believes will win over both payers and patients—lower prices. Arcutis set an $825 wholesale price for each tube of its topical drug, roflumilast, which will be marketed under the brand name “Zoryve.” By comparison, Dermavant … Read more

Carrot Health founder launches SPV-only health tech VC fund

Carrot Health founder launches SPV-only health tech VC fund

Two weeks ago, a team of four founders launched Engage Venture Partnersa Minneapolis-based venture capital firm focused on early stage medical tech companies. Engage is situated in Minnesota’s Medical Alley. With more than 1,000 healthcare tech companies calling the region home, the area is one of the country’s hottest incubators for medical technology innovation. The … Read more

The Apple report outlines its vision for advancing personal health, supporting clinicians

The Apple report outlines its vision for advancing personal health, supporting clinicians

Apple is providing a snapshot of how its products are helping two categories of healthcare: consumers’ personal health and fitness and the general medical community. In both categories of healthcare, Apple is working with third-party developers, health institutions and organizations to provide innovative technology, the company said in a nearly 60-page report. “We believe passionately … Read more

Coverage delays exacerbate inequity for Medicare beneficiaries

Coverage delays exacerbate inequity for Medicare beneficiaries

Imagine you’re diagnosed with a serious illness – bad news. But don’t worry, there’s a treatment – ​​good news. It is clinically tested, FDA-authorized, and has been shown to have a lower risk of complications or side effects than traditional treatments. Great news, right? Well, only if you can afford to pay for it out-of-pocket. … Read more

FDA hits pause on Beam Therapeutics’ off-the-shelf cell therapy for blood cancers

FDA hits pause on Beam Therapeutics’ off-the-shelf cell therapy for blood cancers

A Beam Therapeutics cell therapy whose precise genetic edits are intended to make it a better cancer fighter is now under an FDA clinical hold before a single patient has been dosed with the experimental treatment. Beam submitted its investigational new drug application to the regulator in late June. On Monday, Cambridge, Massachusetts-based Beam said … Read more